Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: Results from the TEAR trial Academic Article uri icon

Overview

MeSH Major

  • Antirheumatic Agents
  • Arthritis, Rheumatoid

abstract

  • Clinical data collected early after starting or escalating disease-modifying antirheumatic drug/biologic treatment could accurately predict LDA at 1 year in patients with early RA. For patients predicted to be nonresponders, treatment could be changed at 12 weeks to optimize outcomes.

publication date

  • May 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3694569

Digital Object Identifier (DOI)

  • 10.3899/jrheum.120715

PubMed ID

  • 23588939

Additional Document Info

start page

  • 572

end page

  • 8

volume

  • 40

number

  • 5